CERTAINTY – Japan
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…
Danielle Pillsbury2024年5月7日
CERTAINTY – China
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical researchers…
Danielle Pillsbury2024年5月7日
CERTAINTY – South Korea
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…
Danielle Pillsbury2024年5月7日
Certara Reports First Quarter 2024 Financial Result
Reiterates Full Year 2024 Financial Guidance PRINCETON, N.J.— May 7, 2024-- Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a…
Jim Gallagher2024年5月7日
Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future
The article "Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future" by Karen Rowland…
Jim Gallagher2024年5月6日
Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model
The rapid growth in the use of pediatric physiologically based pharmacokinetic (PBPK) models, particularly for…
Jim Gallagher2024年5月6日
RAPS Sponsored Webcast: Regulatory & Tech Advances in Drug Safety Reporting
Meeting the escalating global demand for new medications requires expediting regulatory submission development. Documenting drug…
Danielle Pillsbury2024年5月3日
